Comparison of the direct platelet immunofluorescence test (direct PIFT) with a modified direct monoclonal antibody‐specific immobilization of platelet antigens (direct MAIPA) in detection of platelet‐associated IgG
Glycoprotein (GP)‐specific platelet‐associated IgG (PA‐IgG) may be demonstrable in autoimmune‐mediated thrombocytopenia. We studied 159 consecutive patients with histories of thrombocytopenia by a modified direct monoclonal antibody‐specific immobilization of platelet antigens (direct MAIPA) assay, which immobilizes GP IIb/IIIa, GP Ib/IX and GP Ia/IIa simultaneously. This modification requires smaller quantities of platelets than standard measurements performed separately. PA‐IgG was present in 84/159 (53%) patients, as shown by the direct platelet immunofluorescence test (PIFT) with flow cytometry as a reference. PA‐IgG against GP IIb/IIIa and/or GP Ib/IX and/or GP Ia/IIa was noted in 46 patients (29%), of whom 93% (43/46) were also PA‐IgG positive. The amount of PA‐IgG detected by PIFT correlated directly with that detected by direct MAIPA (r=0.71; PP<0.001). Direct PIFT and direct MAIPA divided the patients into asymmetric subgroups. However, the relative roles of these tests in the diagnosis of autoimmune‐mediated thrombocytopenia await further studies.